Metformin is a biguanide that is postulated to potentiate insulin sensitivity by inhibition of mitochondrial enzymes and is generally the first-line medical treatment for diabetes mellitus type 2 [8]. This evidence concerns the gene INS and type 2 diabetes mellitus.